Aether Bio
Founded 2017 · 107 employees on LinkedIn · 18 known investors
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy. Its products serve additive manufacturing users in production, field repair, and prototyping settings.
Also known as Aether · Aether Biomachines
Founders & leadership
Aether Bio was founded in 2017 by Pavle Jeremic and Jay Zaveri.


Investors · 18
Also in the syndicate · 2
Company profile
researched Aug 2026Aether Bio (also referred to as Aether Biomachines) develops AI-designed proteins and derived industrial products. Its core technology is a Protein Function Model intended to identify novel proteins with novel functions, trained on data generated internally by a robotic high-throughput screening laboratory that the company says runs millions of micro-scale experiments. The company states that its proprietary automation hardware enables massively parallelized experimentation, producing datasets larger than those achievable with commercially available laboratory automation, and that automated experimentation and rapid iteration are used to move candidate proteins from discovery through prototype to production.
The commercial product line centers on additives for polymer additive manufacturing. The RapidPrint series consists of reinforced nylon filaments containing Aether's proprietary additive, aimed at faster and stronger FFF/FDM printing for defense, aerospace, and industrial manufacturing users. The Ultra series comprises high carbon fiber loaded filaments with the same additive, targeting demanding applications requiring stiffness and durability. Two further programs are described as in development: additives enabling an aerospace-grade, aluminum-replacing polymer series for lightweighting, and AI-designed proteins for selective extraction and separation of critical minerals such as rare earths, lithium, nickel, and germanium from domestic resources.
Business model
Aether sells physical products derived from its protein and materials platform, including reinforced nylon and carbon-fiber-loaded 3D printing filaments containing its proprietary additive, and also works with clients on a selective partnership basis.
Traction
The company announced that AI-developed next-generation aerospace materials have entered mass production, describing the scaling of novel materials to industrial quantities, and launched the RapidPrint filament product line.
Latest developments
Recent announcements include the launch of the RapidPrint series, a $15M financing backed by Tribe Capital, Natural Capital, and Henkel Corporation among others, and the move of AI-developed aerospace materials into mass production.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself as bridging AI-driven protein discovery and industrial-scale materials manufacturing, framing its work around reindustrializing American manufacturing.
Technology
A Protein Function Model trained on in-house experimental data from a robotic high-throughput screening lab, paired with proprietary automation hardware for massively parallelized micro-scale experimentation; outputs are validated through automated experimentation and iteration and translated into additives and proteins for materials and minerals processing.
Go-to-market
Direct product sales of filament series alongside selective client partnerships, supported by public announcements of product launches and manufacturing milestones.
Additive manufacturing users in defense, aerospace, and industrial manufacturing, plus prospective partners in critical minerals processing.
Geography
United States; critical minerals work is focused on domestic resources.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 3
launches, deals, and filingsFinancing to advance AI-designed proteins for advanced materials and critical mineral extraction.
$15M source ↗
The company announced it had scaled novel AI-developed materials to industrial quantities, moving from discovery to manufacturing.
Aether launched RapidPrint, reinforced nylon filaments with a proprietary additive said to enable faster print speeds while maintaining mechanical properties for aerospace, defense, and industrial additive manufacturing users.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- Aether Bioaetherbio.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Aether Bio do?
- Aether Bio uses an AI protein function model and a robotic high-throughput lab to design proteins for advanced materials and minerals.
- Who founded Aether Bio?
- Aether Bio was founded by Pavle Jeremic, Jay Zaveri in 2017.
- Who are Aether Bio's investors?
- Aether Bio's investors include 4DX Ventures, Abstract Ventures, Artis Ventures, Blue Bear Ventures, BoxGroup, Calm Ventures, Evolution VC Partners, Good AI Capital and 8 more.





